Through time-series scRNA-seq analysis, Trudy Oliver and colleagues demonstrated that MYC can drive the dynamic evolution of SCLC subtypes, promoting a temporal shift from ASCL1+ to NEUROD1+ and YAP1+ SCLC states (Ireland et al., 2020). The gene discussed is MYC; the disease is small cell lung carcinoma.